These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10715372)

  • 1. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
    Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S
    Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
    Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
    Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
    Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
    Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.
    Niruthisard S; Roddy RE; Chutivongse S
    Sex Transm Dis; 1991; 18(3):176-9. PubMed ID: 1658953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.
    Keller MJ; Carpenter CA; Lo Y; Einstein MH; Liu C; Fredricks DN; Herold BC
    PLoS One; 2012; 7(10):e46901. PubMed ID: 23056520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E; Perdigão A; Souza MH; Mauck C; Waller D; Zaneveld L; Faúndes A
    Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).
    Garg S; Anderson RA; Chany CJ; Waller DP; Diao XH; Vermani K; Zaneveld LJ
    Contraception; 2001 Jul; 64(1):67-75. PubMed ID: 11535216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan.
    Elias CJ; Coggins C; Alvarez F; Brache V; Fraser IS; Lacarra M; Lähteenmäki P; Massai R; Mishell DR; Phillips DM; Salvatierra AM
    Contraception; 1997 Dec; 56(6):387-9. PubMed ID: 9494773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of properties of Amphora (Acidform) contraceptive vaginal gel.
    Nelson AL
    Expert Opin Drug Saf; 2018 Sep; 17(9):935-943. PubMed ID: 30136907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The postcoital test as a method of evaluating a contraceptive jelly.
    Cohen MR; Kaye BM
    J Am Med Assoc; 1953 Jul; 152(11):1042-3. PubMed ID: 12255243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Condoms and urinary tract infections: is nonoxynol-9 the problem or the solution?
    Steiner MJ; Cates W
    Epidemiology; 1997 Nov; 8(6):612-4. PubMed ID: 9345658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.
    Su HI; Schreiber CA; Fay C; Parry S; Elovitz MA; Zhang J; Shaunik A; Barnhart K
    Contraception; 2011 Nov; 84(5):525-32. PubMed ID: 22018129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of nonoxynol-9-containing spermicides on urogenital infection.
    McGroarty JA; Reid G; Bruce AW
    J Urol; 1994 Sep; 152(3):831-3. PubMed ID: 8051730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonoxynol-9 in lubricated condoms. Results of a study in female prostitutes.
    Ward H; De La Court A; Kitchen V
    Sex Transm Dis; 1996; 23(5):413-4. PubMed ID: 8885074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
    Mayersak JS; Viviano CJ
    J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina).
    Patton DL; Kidder GG; Sweeney YC; Rabe LK; Hillier SL
    Am J Obstet Gynecol; 1999 May; 180(5):1080-7. PubMed ID: 10329859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
    Mauck CK; Weiner DH; Ballagh SA; Creinin MD; Archer DF; Schwartz JL; Pymar HC; Lai JJ; Rencher WF; Callahan MM;
    Contraception; 2004 Jul; 70(1):77-83. PubMed ID: 15208057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.